ITRM - Iterum Therapeutics plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 595.99M
Enterprise Value 347.27M
Trailing P/E N/A
Forward P/E 1-1.98
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)134.25
Price/Book (mrq)1.86
Enterprise Value/Revenue 366.11
Enterprise Value/EBITDA 6-0.56

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-21.30%
S&P500 52-Week Change 36.70%
52 Week High 311.22
52 Week Low 34.70
50-Day Moving Average 36.63
200-Day Moving Average 36.75

Share Statistics

Avg Vol (3 month) 36.47k
Avg Vol (10 day) 33.29k
Shares Outstanding 514.37M
Float 4.49M
% Held by Insiders 18.97%
% Held by Institutions 175.71%
Shares Short (Jun 28, 2019) 432.45k
Short Ratio (Jun 28, 2019) 43.33
Short % of Float (Jun 28, 2019) 40.59%
Short % of Shares Outstanding (Jun 28, 2019) 40.23%
Shares Short (prior month May 31, 2019) 453.42k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-11,863.22%

Management Effectiveness

Return on Assets (ttm)-67.42%
Return on Equity (ttm)-153.54%

Income Statement

Revenue (ttm)715k
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-80.60%
Gross Profit (ttm)869k
EBITDA -84.68M
Net Income Avi to Common (ttm)-85.49M
Diluted EPS (ttm)-6.97
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)70.47M
Total Cash Per Share (mrq)4.9
Total Debt (mrq)21.75M
Total Debt/Equity (mrq)42.13
Current Ratio (mrq)4.36
Book Value Per Share (mrq)3.59

Cash Flow Statement

Operating Cash Flow (ttm)-79.3M
Levered Free Cash Flow (ttm)-46.73M